⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11190350 | 1.00 | — | — | |
| SCHEMBL1305583 | 0.71 | — | — | |
| SCHEMBL2011308 | 0.71 | — | — | |
| SCHEMBL22288582 | 0.71 | — | — | |
| SCHEMBL5390716 | 0.67 | — | — | |
| SCHEMBL1060958 | 0.67 | — | — | |
| SCHEMBL5163446 | 0.66 | — | — | |
| SCHEMBL5161198 | 0.66 | — | — | |
| SCHEMBL5161134 | 0.65 | — | — | |
| SCHEMBL2464690 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230348884-A1 | Fluorescent Biosensor for Rapid Determination of L-arginine | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2023-11-02 | — | — | US | claimed |
| EP-4216961-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF CORONAVIRUS INFECTION | Lighthouse Pharmaceuticals, Inc. (US) | 2023-08-02 | — | — | EP | claimed |
| US-9630934-B2 | Fumarate compounds, pharmaceutical compositions thereof, and methods of use | Nguyen, Mark Quang (US) | 2017-04-25 | — | — | US | claimed |
| US-20160297770-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | NGUYEN MARK QUANG (US) | 2016-10-13 | — | — | US | claimed |
| WO-2016133832-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | NGUYEN MARK QUANG (US) | 2016-08-25 | — | — | WO | claimed |
| US-20160237041-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | Nguyen, Mark Quang (US) | 2016-08-18 | — | — | US | claimed |
| WO-2016127186-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | NGUYEN MARK QUANG (US) | 2016-08-11 | — | — | WO | claimed |
| US-20160229819-A1 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | Nguyen, Mark Quang (US) | 2016-08-11 | — | — | US | claimed |
| US-9409872-B1 | Fumarate compounds, pharmaceutical compositions thereof, and methods of use | Nguyen, Mark Quang (US) | 2016-08-09 | — | — | US | claimed |
| WO-2010124100-A1 | NOVEL SELECTIVE 5-HT4 RECEPTOR ANTAGONISTS | IMMUNE CONTROL, INC. (US) | 2010-10-28 | — | — | WO | claimed |
| EP-0138539-B1 | 2-AZACYCLOALKYLTHIOPENEM DERIVATIVES | PFIZER INC. (US) | 1989-03-15 | — | — | EP | claimed |
| US-4772597-A | ANTIBIOTICS | PFIZER INC. (US) | 1988-09-20 | — | — | US | claimed |
| EP-0138539-A1 | 2-Azacycloalkylthiopenem derivatives | PFIZER INC. (US) | 1985-04-24 | — | — | EP | claimed |
| US-4464361-A | Adenosine derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-08-07 | — | — | US | claimed |
| CN-117940557-A | Method for preparing modified tumor-infiltrating lymphocytes and application of modified tumor-infiltrating lymphocytes in adoptive cell therapy | 艾欧凡斯生物治疗公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117561080-A | anti-GAL 3 antibody formulations and methods of use thereof | 真和制药有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-109715805-B | Nucleic acid-polypeptide compositions and uses thereof | 艾维迪提生物科学公司 | 2024-01-05 | — | — | CN | disclosed |
| EP-0138539-B1 | 2-AZACYCLOALKYLTHIOPENEM DERIVATIVES | PFIZER INC. (US) | 1989-03-15 | — | — | EP | disclosed |
| US-4772597-A | ANTIBIOTICS | PFIZER INC. (US) | 1988-09-20 | — | — | US | disclosed |
| EP-0138539-A1 | 2-Azacycloalkylthiopenem derivatives | PFIZER INC. (US) | 1985-04-24 | — | — | EP | disclosed |